Research graph
References from GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History. Local targets link to admitted publications; unresolved targets remain external evidence.
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials.
10.1016/s2213-8587(21)00203-5 · 2021 · External reference
Pharmacologic approaches to glycemic treatment: standards of care in diabetes—2024.
10.2337/dc24-s009 · 2024 · External reference
2020 expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes.
10.1016/j.jacc.2020.05.037 · 2020 · External reference
Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
10.1200/jco.2016.70.5400 · 2017 · External reference
A population-based study of cardiovascular disease mortality risk in US cancer patients.
10.1093/eurheartj/ehz766 · 2019 · External reference
GLP-1 RA use and survival among older adults with cancer and type 2 diabetes.
10.1001/jamanetworkopen.2025.21887 · 2025 · External reference
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement.
10.1016/s0140-6736(07)61602-x · 2007 · External reference
Unresolved reference
External reference
10.15620/cdc/174616
10.15620/cdc/174616 · External reference
